Early extended interval dosing of rituximab in multiple sclerosis: A comparative cohort study on efficacy and safety
DOI:
10.1016/j.msard.2025.106400
Publication Date:
2025-03-22T01:25:03Z
AUTHORS (9)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....